Pathophysiologic Differences Among Asians, Native Hawaiians, and Other Pacific Islanders and Treatment Implications
William C. Hsu(Beth Israel Deaconess Medical Center), Richard F. Arakaki(University of Hawaiʻi at Mānoa), Gertraud Maskarinec(Cancer Center of Hawaii), Alka M. Kanaya(San Francisco General Hospital), Andrew J. Karter(Kaiser Permanente), Fahina Tavake-Pasi, Wilfred Y. Fujimoto(University of Washington), Ranjita Misra(Texas A&M University), Mele A. Look(University of Hawaiʻi at Mānoa), Wahida Karmally(Columbia University), Edward J. Boyko(University of Washington), George L. King(Joslin Diabetes Center)
Cited by 86
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979